Masimo Corp. (MASI) Receives Consensus Rating of “Buy” from Analysts
Masimo Corp. (NASDAQ:MASI) has been assigned an average recommendation of “Buy” from the six brokerages that are presently covering the company. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $56.00.
A number of analysts have commented on the company. Zacks Investment Research lowered Masimo Corp. from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 4th. Piper Jaffray Cos. reissued an “overweight” rating and issued a $55.00 target price (up previously from $52.00) on shares of Masimo Corp. in a report on Friday, August 5th. BTIG Research reaffirmed a “hold” rating on shares of Masimo Corp. in a report on Friday, August 5th. Finally, Wedbush reaffirmed an “outperform” rating and issued a $63.00 price objective (up previously from $60.00) on shares of Masimo Corp. in a report on Thursday, August 4th.
In other news, EVP Yongsam Lee sold 30,000 shares of the business’s stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $60.50, for a total value of $1,815,000.00. Following the transaction, the executive vice president now directly owns 93,000 shares in the company, valued at $5,626,500. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Joe E. Kiani sold 33,536 shares of the business’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $60.00, for a total value of $2,012,160.00. Following the completion of the transaction, the chief executive officer now owns 152,777 shares in the company, valued at $9,166,620. The disclosure for this sale can be found here. Corporate insiders own 16.60% of the company’s stock.
Several institutional investors have recently made changes to their positions in the stock. Aperio Group LLC increased its position in shares of Masimo Corp. by 27.3% in the first quarter. Aperio Group LLC now owns 15,761 shares of the company’s stock valued at $659,000 after buying an additional 3,379 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its position in shares of Masimo Corp. by 0.7% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 56,685 shares of the company’s stock valued at $2,372,000 after buying an additional 400 shares during the last quarter. Ngam Advisors L.P. acquired a new position in shares of Masimo Corp. during the first quarter valued at approximately $461,000. Menta Capital LLC increased its position in shares of Masimo Corp. by 23.5% in the first quarter. Menta Capital LLC now owns 22,100 shares of the company’s stock valued at $925,000 after buying an additional 4,200 shares during the last quarter. Finally, Huntington Asset Advisors Inc. acquired a new position in shares of Masimo Corp. during the first quarter valued at approximately $513,000. Institutional investors and hedge funds own 79.88% of the company’s stock.
Shares of Masimo Corp. (NASDAQ:MASI) traded up 0.90% during mid-day trading on Wednesday, reaching $59.19. The company had a trading volume of 105,456 shares. Masimo Corp. has a one year low of $33.03 and a one year high of $60.81. The stock has a market capitalization of $2.92 billion, a P/E ratio of 31.04 and a beta of 0.70. The firm has a 50 day moving average of $59.19 and a 200-day moving average of $51.84.
Masimo Corp. (NASDAQ:MASI) last posted its earnings results on Wednesday, August 3rd. The company reported $0.57 EPS for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.16. The business earned $172.64 million during the quarter, compared to analyst estimates of $166.02 million. Masimo Corp. had a return on equity of 29.07% and a net margin of 15.40%. The company’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.36 EPS. Analysts forecast that Masimo Corp. will post $2.02 EPS for the current fiscal year.
About Masimo Corp.
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Stock Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related stocks with our FREE daily email newsletter.